Del(9Cd3g-Cd3e)1Csk
Targeted Allele Detail
|
Symbol: |
Del(9Cd3g-Cd3e)1Csk |
Name: |
deletion, Chr 9, Chugai Pharmaceutical Co, Ltd; deletion, Chr 9, Chugai Pharmaceutical Co, Ltd 1 |
MGI ID: |
MGI:5910028 |
Synonyms: |
Del1Csk, mCd3 edg- |
Gene: |
Del(9Cd3g-Cd3e)1Csk Location: unknown Genetic Position: Chr9, Syntenic
|
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutations: |
|
Insertion, Intergenic deletion, Intragenic deletion
|
|
|
Del(9Cd3g-Cd3e)1Csk involves 3 genes/genome features (Cd3g, Cd3d, Cd3e)
View all
|
|
|
Mutation details: A neomycin resistance cassette with a 5' loxP site was inserted upstream of Cd3e. A Rox-flanked hygromycin resistance cassette with a 5' loxP site was inserted downstream of Cd3g. Cre- and Dre-mediated recombination removed Cd3e, Cd3d and Cd3g along with both selection cassettes.
(J:243702)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Del(9Cd3g-Cd3e)1Csk Mutation: |
0 strains or lines available
|
|
Original: |
J:243702 Ueda O, et al., Entire CD3epsilon, delta, and gamma humanized mouse to evaluate human CD3-mediated therapeutics. Sci Rep. 2017 Apr 03;7:45839 |
All: |
1 reference(s) |
|